Skip to main content
NOVAREX Co., Ltd. logo

NOVAREX Co., Ltd. — Investor Relations & Filings

Ticker · 194700 ISIN · KR7194700001 KO Manufacturing
Open in API
Filings indexed 335 across all filing types
Latest filing 2022-03-18 Audit Report / Informat…
Country KR South Korea
Listing KO 194700

About NOVAREX Co., Ltd.

https://www.novarex.co.kr/en/

NOVAREX Co., Ltd. is a research and development-driven company specializing in health functional foods and supplements. It operates as an Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM), offering end-to-end services that encompass product planning, development, manufacturing, and delivery. Through its Life Science Research Center, the company develops novel functional ingredients validated by thorough verification and human application testing. NOVAREX manufactures a diverse range of product formulations, including tablets, capsules, powders, and stick jellies. A key competitive advantage is its extensive portfolio of individually recognized raw materials, underscoring its focus on scientific innovation and quality.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is titled '감사보고서 제출' (Submission of Audit Report) and provides a summary of the audit opinion, financial highlights (assets, liabilities, equity, profit/loss), and auditor information. While it contains financial data, it is a regulatory announcement confirming the submission of the audit report to the exchange, rather than the full annual report (10-K) or a standalone audit report (AR). According to the 'Menu vs Meal' rule, this is a report publication announcement. FY 2021
2022-03-18 Korean
사업보고서 (2021.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Consolidated Audit Report' (연결감사보고서) for Novarex Co., Ltd. for the fiscal year ending December 31, 2021. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. This document represents the full annual financial reporting package, which is classified as an Annual Report (10-K) in the provided schema. FY 2021
2022-03-18 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Novarex regarding a decision to pay cash dividends. It specifies the dividend amount per share, the dividend record date, the total dividend amount, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV) as it provides specific details regarding dividend payments to shareholders.
2022-03-07 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of an Annual General Meeting (AGM) for the company 'Novarex'. It details the meeting date, location, agenda items (such as financial statement approval, dividend approval, and director/auditor appointments), and provides specific details on board and committee member nominations. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and request their votes, which aligns with the definition of a Proxy Solicitation & Information Statement (PSI).
2022-03-07 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Novarex Co., Ltd. It contains the meeting agenda, details on voting procedures (including electronic voting), and management information such as director activities and business outlook. This type of document is a standard proxy statement/information circular provided to shareholders to inform them of upcoming meetings and solicit votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2022-03-07 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy) for Novarex Co., Ltd. It contains detailed information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures (electronic/written), and specific agenda items such as the approval of financial statements. This document is a standard proxy solicitation material provided to shareholders to request their votes for the meeting.
2022-03-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.